FK778

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for FK778, covering 2008-04-17 to 2012-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy [Phase 2]